What this means
This trial tested a single shot into the knee for painful osteoarthritis. It checked safety, how well people tolerated it, and how the body handled the drug. No results have been posted, so we cannot yet say how it worked.
Plain-English summary written by an AI model from the registry listing.
- Status
- Completed
- Who can join
- Ages 40–85
- Where
- 7 sites, including California, Florida, Missouri
The science
- Registered title
- A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee
- Trial ID
- NCT03513016 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Osteoarthritis, Knee
- What is tested
- UBX0101, Placebo
- Sponsor
- Unity Biotechnology, Inc.
- Ages
- 40 Years to 85 Years
- Dates
- First posted May 1, 2018 · updated Apr 20, 2020
Registry summary
A study to evaluate safety, tolerability, and pharmacokinetics of a single intra-articular injection of UBX0101 in patients diagnosed with painful osteoarthritis of the knee.
Sites (7)
- TriWest Research Associates, El Cajon, California, United States
- BioSolutions Clinical Research Center, La Mesa, California, United States
- Well Pharma Medical Research, Miami, Florida, United States
- Center for Pharmaceutical Research, Kansas City, Missouri, United States
- Clinical Research Consortium, Las Vegas, Nevada, United States
- Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States
- Metroplex Clinical Research Center, Dallas, Texas, United States
More aging trials in these states
California · Florida · Missouri · Nevada · Pennsylvania · Texas